oncology

Singapore, mergers and acquisitions, contract research organisations, Oncology

Singaporeā€™s Hiro Acquires US Oncology CRO To Expand Its Global Footprint

Anika Sharma

Singapore-based Harvest Integrated Research Organization, known as HiRO, is making a significant move to bolster its global presence through the ...

Gilead Targets $3B in Oncology Revenue with 3 Key Drugs

Gileadā€™s $3B Oncology Milestone: Trodelvy, Tecartus and Yescarta Lead the Way in 2023

SG Tylor

Gilead Sciences has been making significant strides in the oncology space, fueled by the success of its rising star drug, ...

How Pfizerā€™s Executive Leadership Will Shape Oncology R&D Strategy

Pfizer reveals executive leadership to advance its oncology R&D strategy

SG Tylor

Source – Pfizer Pfizer has unveiled significant executive leadership changes aimed at advancing its commitment to research and development of ...

Repercussions of Oncologic Drug Shortages Shift Responsibility to Major Payers

Repercussions of Oncologic Drug Shortages Shift Responsibility to Major Payers

SG Tylor

Introduction In the realm of healthcare, access to life-saving medications is of paramount importance. Unfortunately, the occurrence of oncologic drug ...

Can artificial intelligence alter how oncology is practiced?

Artificial Intelligence in oncology: Can artificial intelligence alter how oncology is practiced?

SG Tylor

Artificial Intelligence in Oncology: A big trend right now is artificial intelligence (AI). Even though AI has long been a ...